The Switzerland market ended marginally up on Tuesday after swinging between gains and losses, after a somewhat lackluster session.
The benchmark SMI ended up 12.37 points or 0.11% at 10,964.81. The index moved between 10,915.76 and 10,979.14.
Roche Holding gained 1.89% after the company’s unit Genentech announced positive results from the Phase III INAVO120 study of the combination of inavolisib with palbociclib and fulvestrant as a potential first-line treatment option in metastatic breast cancer.
Geberit climbed about 2.2%. ABB, Kuehne & Nagel, Lonza Group and Sika ended higher by 1 to 1.5%.
Richemont advanced nearly 1%. Zurich Insurance Company, Logitech International and Holcim posted modest gains.
UBS Group, Alcon and Novartis ended down 1.82%, 1.56% and 1.25%, respectively.
In the Mid Price Index, ams OSRAM AG soared 9.17%. Julius Baer gained nearly 3.5%, while Meyer Burger Tech and Sandoz both gained 3.03%.
Belimo Holding and Georg Fischer ended higher by 2.1% and 1.9%, respectively.
Straumann Holding and Tecan Group both ended more than 1.5% down. SIG Combibloc, Swatch Group, Barry Callebaut and Helvetia also closed weak.
Market Analysis
Swiss Market Ends Slightly Up
2023-12-05 18:28:57
